Abstract
We investigated the hypothesis that atrial natriuretic peptide (ANP) attenuates lymph vessel pumping. In the present experiments, isolated bovine lymphatic vessels were cannulated at each end to create inflow and outflow ports for the administration of Krebs' solution (vehicle) or ANP and for the measurement of fluid pumped by the vessel respectively. Once cannulated, the vessels were placed in a temperature-regulated bath circulated with oxygenated vehicle. Transmural pressure was regulated by the height of a fluid-filled reservoir. Lymph pump activity was assessed by measuring the volume of outflow every ten minutes. ANP was administered at concentrations of 0 (control), 0.1, 1.0, 10 and 100 nM. Data were expressed as a percentage of the value in the control period. When compared with vehicle, ANP produced a significant inhibition of lymph pump activity by 7.7 at 0.1 nM, 24.2% at 10 nM and 38.26% at 100 nM averaged over the hour for which the vessels were exposed to each concentration. Thus ANP inhibits lymph pumping concentration dependently. This may be yet another mechanism by which ANP exerts its haemodynamic effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Almeida FA, Suzuki M, Maack T (1989) Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. Life Sci 39:1193–1199
Anand-Srivastava MB, Trachte GJ (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45:455–497
Anderson WD, Kulik TJ, Mayer JE (1991) Inhibition of contraction of isolated lymphatic ducts by atrial natriuetic peptide. Am J Physiol 260:R610-R614
Ando S-I, Imaizumi T, Harada S, Hirooka Y, Takeshita A (1992) Atrial natriuretic peptide increases human capillary filtration and venous distensibility. J Hypertens 10:451–457
Aukland K, Reed RK (1993) Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73:1–78
Barbee RW, Harrison-Bernard LM, Carmines PK (1992) Microvascular effects of atrial natriuretic peptide in rat cremaster. Peptides 13:1181–1185
Burnett JC, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, Opgenorth TJ, Redder GS (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231:1145–1147
Campbell PJ, Skorecki KL, Logan AG, Wong P-Y, Leung WM, Greig P, Blendis LM (1988) Acute effects of peritoneovenous shunting on plasma atria] natriuretic peptide in cirrhotic patients with massive regractory ascites. Am J Med 84:112–119
Chien YW, Frohlich ED, Trippodo N (1987) Atrial natriuretic peptide increases resistance to venous return in rats. Am J Physiol 252:H894-H899
Eisenhoffer J, Yuan Z-Y, Johnston MG (1995) Evidence that thel-arginine pathway plays a role in the regulation of pumping activity in bovine mesenteric lymphatic vessels. Microvasc Res 50:249–259
Eliades D, Swindell B, Johnston J, Pamnani M, Haddy FJ (1989) Effects of ANP on venous pressures and microvascular protein permeability in dog forelimb. Am J Physiol 257: H272-H279
Elias RM, Johnston MG (1988) Modulation of fluid pumping in isolated bovine mesenteric lymphatics by a thromboxane/endoperoxide analogue. Prostaglandins 36:97–106
Elias RM, Wandolo G, Ranadive NR, Eisenhoffer J, Johnston MG (1990) Lymphatic pumping in response to changes in transmural pressure is modulated by erythrolysate/hemoglobin. Circ Res 67:1097–1106
Frank HJL, Pedram A, Hu RM, Gelfand RM, Levin ER (1994) Regulation of atrial natriuretic peptide receptors in brain capillary endothelial cells. Endocr J [UK] 2:33–40
Garcia R, Thibault G, Cantin M (1987) Correlation between cardiac hypertrophy and plasma levels of atrial natriuretic factor in non-spontaneous models of hypertension in the rat. Biochem Biophys Res Commun 145:533–541
Groban L, Cowley AWJr, Ebert TJ (1990) Atrial natriuretic peptide augments forearm capillary filtration in humans. Am J Physiol 259:H258-H263
Hall C, Tølløfsrud S, Bjerkelund C-E, Noddeland H, Sundsfjord J (1992) Plasma concentrations of atrial peptides ANF (1–98) and ANF (99–126) after intravenous infusion: effect of infusate temperature. Clin Physiol 12:185–193
Hanley CA, Elias RM, Mowat HZ, Johnston MG (1989) Suppression of fluid pumping in isolated bovine mesenteric lymphatics by interleukin-1: interaction with prostaglandin E2. Microvas Res 37:218–229
Huxley VH, Tucker VL, Verburg KM, Freeman RH (1987) Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Citc Res 60:304–307
Ohhashi T, Fukushima S, Azuma T (1977) Vaso vasorum within the media of bovine mesenteric lymphatics. Proc Soc Exp Biol Med 154:582–586
Ohhashi T, Watanabe N, Kawai Y (1990) Effects of atrial natriuretic peptide on isolated bovine mesenteric lymph vessels. Am J Physiol 259: H42-H47
Peters J, Neuser D, Schaden W, Arndt JO (1992) Atrial natriuretic peptide decreases hepatic and cardiac blood content, but increases intestinal blood content in supine humans. Basic Res Cardiol 87:250–262
Roddie IC (1990) Lymph transport mechanisms in peripheral lymphatics. News Physiol Sci 5:85–89
Röelleke T, Berke B, Arndt JO (1994) Atrial natriuretic peptide alters neither capillary filtration nor vascular compliance of both skin and skeletal muscle of humans. Basic Res Cardiol 89:192–205
Trippodo NC, Barbee RW (1987) Atrial natriuretic factor decreases whole-body capillary absorption in rats. Am J Physiol 252:R915-R920
Williamson JR, Holmberg SW, Chang K, Marvel J, Sutera SP, Needleman P (1989) Mechanisms underlying atriopeptininduced increases in hematocrit and vascular permeation in rats. Circ Res 64:890–899
Yandle TG, Fitzpatrick MA, Espiner EA, Richards AM, Fisher S, Carne A (1991) Ovine atrial natriuretic factor:sequence of circulating forms and metabolism in plasma. Peptides 12:279–283
Yonemaru M, Ishii K, Murad F, Raffin TA (1992) Atriopeptininduced increases in endothelial cell permeability are associated with elevated cGMP levels. Am J Physiol 263:L363-L369
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Atchison, D.J., Johnston, M.G. Atrial natriuretic peptide attenuates flow in an isolated lymph duct preparation. Pflugers Arch. 431, 618–624 (1996). https://doi.org/10.1007/BF02191911
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02191911